期刊文献+

维格列汀对T2DM患者抗氧化应激作用的研究

下载PDF
导出
摘要 目的:观察维格列汀对2型糖尿病(T2DM)患者血清丙二醛(MDA)、超氧化物歧化酶(SOD)和8-羟基脱氧尿苷(8-hydroxydeoxyguanosine,8-OHd G)水平的影响,了解其抗氧化应激作用。方法:30例血糖控制欠佳的T2DM患者在常规治疗基础上加用维格列汀治疗,24周后观察治疗前后检测血清MDA、SOD和8-Ohd G水平变化。结果:治疗24周后,治疗组MDA和8-OHd G水平较治疗前明显下降(P<0.05),差异显著;SOD水平较治疗前上升(P<0.05),差异显著。结论:维格列汀能降低T2DM患者MDA、8-OHd G和升高SOD水平,减轻T2DM患者的体内氧化应激。
出处 《北方药学》 2015年第5期151-152,共2页 Journal of North Pharmacy
  • 相关文献

参考文献9

  • 1Akarte AS1, Srinivasan BP, Gandhi S. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-lc mRNA levels and stimu- lates 13-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes[J]. J Diabetes Compli- cations, 2012, 26(4) : 266-274. 被引量:1
  • 2Kasai H.Analysis of a form of oxidative DNA damage, 8-lay-droxy-2"-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis[J]. Mutat Res, 1997,387( 3 ) : 147-163. 被引量:1
  • 3Moazzen H, Lu X, Liu M, et al. Pregestational Diabetes In- duces Fetal Coronary Artery Malformation via Reactive Oxygen Species Signaling[J]. Diabetes,2014, pii: DB_140190. 被引量:1
  • 4Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of mela- tonin and oxidative stress [J].Diabetes Metab Syndr,2014,pii: S1871-4021. 被引量:1
  • 5Raza H, John A, Howarth FC. Increased Oxidative Stress and Mitochondrial Dysfunction in Zucker Diabetic Rat Liver and Brain [J]. Cell Physiol Biochem,2015,35(3 ) : 1241-1251. 被引量:1
  • 6Yao XM, Ye SD, Xiao CC, et al. Mefformin alleviates high glucose mediated oxidative stress in rat glomerular mesangial cells by modulation of p38 mitogen-activated protein kinase expression in vitro[J]. Mol Med Rep; 2015,3446. 被引量:1
  • 7Wu LL, Chiou CC, Chang PY,et al. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer[J], atheroscle- rosis and diabetics Clin Chim Acta, 2004,339( 1-2):1-9. 被引量:1
  • 8Wang WJ, Chang CH, Sun MF,et al. DPP-4 inhibitor attenu- ates toxic effects of indoxyl sulfate on kidney tubular cells[J]. PLoS One, 2014,9 (4) : e934-947. 被引量:1
  • 9Tani S, Takabashi A, Nagao K,et al. Effect of dipeptidyl pep- tidase-4 inhibitor, vildagliptin on plasminogen activator inhibitor- 1 in patients with diabetes mellitus [J]. Am J Cardiol, 2015, 115 (4) : 454-460. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部